Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

NCT05627752 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Castrate Resistant Prostate Cancer

Interventions

DRUG: Enzalutamide 40 MG
DRUG: Docetaxel injection

Sponsor

Zhongnan Hospital